Investor Presentations

Friday, February 17, 2023, 8:30 a.m. Local Bermuda Time

Location: Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda

Altamira Therapeutics to Host Investor Call on September 14th

September 14th, 2022, 10:30 a.m. Eastern Time (7:30 a.m. Pacific Time)

Toll-free dial-in number: 1-877-545-0320
International dial-in number:1-973-528-0002
‍
A replay of the call will be available 30 minutes after the live call via the
Investors section of the Altamira website at https://ir.altamiratherapeutics.com/
‍Toll Free replay number: 1-877-481-4010
International replay number: 1-919-882-2331
Replay ID: 46517
Expiration: Wednesday September 28, 2022, 11:59 PM ET.

Webcast

Altamira Therapeutics Sets Full Year 2021 Earnings Call

Tuesday, April 12, 2022, 8:00 a.m. ET

Toll-free Replay: 877-481-4010
International Replay: 919-882-2331
Replay Access Code: 45151

View Presentation

Altamira Therapeutics Sets Full Year 2021 Earnings Call

Tuesday, April 12, 2022, 8:00 a.m. ET

Toll-free Replay: 877-481-4010
International Replay: 919-882-2331
Replay Access Code: 45151

View Presentation

Altamira Therapeutics to Present at the H.C. Wainwright BioConnect Conference, to be held virtually January 10-13, 2022

View Webcast

Altamira Therapeutics to Host Conference Call and Webcast to Provide Business Update on Bentrio™ Program

Monday, September 27, 2021, at 2:00 pm CEST

To participate telephonically, please dial (888) 506-0062 (U.S.) or (973) 528-0011 (international), conference code 590321.
View Webcast

Supporting Materials:

Altamira Therapeutics Business Update September 2021

Altamira Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference, to be held virtually September 13-15, 2021.

View Webcast

Altamira Therapeutics to Report First Half 2021 Financial Results and Provide Business Update

Wednesday, 09/08/21 3:00 pm CEST

Auris Medical Holding Ltd to hold the Special General Meeting

Wednesday, 07/21/21 8:00 am CEST

Description: Auris Medical Holding Ltd will hold the Special General Meeting of Shareholders on July 21, 2021, at 08.00 am CEST in Basel, Switzerland

Supporting Materials:

Auris Medical Notice of the SGM

Auris Medical Holding to Present at LD Micro Invitational XI Conference

Wednesday, 06/09/21 11:00 am EDT

Description: Chairman and CEO Thomas Meyer will present at the LD Micro Invitational XI investor conference on Wednesday June 9, 2021, at 11:00 a.m. EST (Track 2). The event will be webcast live and available via the event homepage.
View Webcast

Auris Medical Business Update June 2021

Thursday, 06/03/21 3:00 pm CEST

Supporting Materials:

Auris Medical Business Update June 2021

Auris Medical to Provide Business Update on AM-301 Program

Tuesday, 04/13/21 8:00 am EDT

Description: Conference Call & Webcast - Rescheduled
Auris Medical will host a conference call and webcast to present a business update. The event will be dedicated in full to the AM-301 program and replace the conference call and webcast which was initially scheduled for March 31, 2021. Further details and webcast information will be provided shortly prior to the event.

Supporting Materials:

Auris Medical Business Update Presentation

7/25/22

Altamira Therapeutics Corporate Presentation Summer 2022

5/12/22

Altamira Therapeutics Corporate Presentation Spring 2022